Advanced search
Publication Cover
Pharmacogenomics Volume 15, 2014 - Issue 4
Submit an article Journal homepage
328
Views
0
CrossRef citations to date
0
Altmetric
Editorial

CYP2D6and Pharmacogenomics: Where Does Future Research Need to Focus? Part 1: Technical Aspects

Andrea Gaedigk1 Division of Clinical Pharmacology & Therapeutic Innovation, Children‘s Mercy Hospital & Clinics & Department of Pediatrics, University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO64108, USA. Correspondence[email protected]
&
J Steven Leeder1 Division of Clinical Pharmacology & Therapeutic Innovation, Children‘s Mercy Hospital & Clinics & Department of Pediatrics, University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO64108, USA.
Pages 407-410 | Published online: 13 Mar 2014

References

  • Zhou SF . Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin. Pharmacokinet.48(11) , 689–723 (2009).
  • Zhou SF . Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin. Pharmacokinet.48(12) , 761–804 (2009).
  • Gaedigk A . Complexities of CYP2D6 gene analysis and interpretation. Int. Rev. Psychiatry25(5) , 534–553 (2013).
  • Gaedigk A , TwistGP, LeederJS. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR. Pharmacogenomics13(1) , 91–111 (2012).
  • Gaedigk A , NdjountcheL, DivakaranK et al. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin. Pharmacol. Ther. 81(2) , 242–251 (2007).
  • Gaedigk A , JaimeLK, BertinoJS Jr et al. Identification of novel cyp2d7–2d6 hybrids: non-functional and functional variants. Front. Pharmacol.1 , 121(2010).
  • Sim SC , DalyAK, GaedigkA. CYP2D6 update: revised nomenclature for CYP2D7/2D6 hybrid genes. Pharmacogenet. Genomics22(9) , 692–694 (2012).
  • Gaedigk A , FuhrU, JohnsonC, BerardLA, BradfordD, LeederJS. CYP2D7–2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction. Pharmacogenomics11(1) , 43–53 (2010).
  • Kramer WE , WalkerDL, O‘KaneDJ et al. CYP2D6: novel genomic structures and alleles. Pharmacogenet. Genomics19(10) , 813–822 (2009).
  • Sim SC , Ingelman-SundbergM. Update on Allele Nomenclature for Human Cytochromes P450 and the Human Cytochrome P450 Allele (CYP-Allele) Nomenclature Database. Methods Mol. Biol.987 , 251–259 (2013).
  • Hicks JK , SwenJJ, GaedigkA. Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization. Curr. Drug Metab. doi:10.2174/1389200215666140202215316 (2014) (Epub ahead of print).
  • Gaedigk A , SimonSD, PearceRE, BradfordLD, KennedyMJ, LeederJS. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin. Pharmacol. Ther.83(2) , 234–242 (2008).
  • Steimer W , ZopfK, von Amelunxen S et al. Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers. Clin. Chem.50(9) , 1623–1633 (2004).
  • Gaedigk A , RiffelAK, Garcia Berrocal B, Garcia-Solaesa V, Davila I, Isidoro-Garcia M. Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test® no-call in the clinical setting. Clin. Chem. Lab. Med. doi:10.1515/cclm-2013-0943 (2014) (Epub ahead of print).
  • Gaedigk A , Isidoro-GarciaM, PearceRE et al. Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations. Eur. J. Clin. Pharmacol. 66(9) , 859–864 (2010).
  • Crews KR , GaedigkA, DunnenbergerHM et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 update. Clin. Pharmacol. Ther. doi:10.1038/clpt.2013.254 (2004) (Epub ahead of print).
  • Hicks JK , SwenJJ, ThornCF et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin. Pharmacol. Ther. 93(5) , 402–408 (2013).
  • Bustin SA , BenesV, GarsonJ et al. The need for transparency and good practices in the qPCR literature. Nat. Methods 10(11) , 1063–1067 (2013).
  • Wang D , PoiMJ, SunX, GaedigkA, LeederJS, SadeeW. Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum. Mol. Genet.23(1) , 268–278 (2013).
  • Ramamoorthy A , LiL, GaedigkA et al. In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4alpha expression. Drug metabolism and disposition: the biological fate of chemicals. Drug Metab. Dispos.40(4) , 726–733 (2012).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.